Surrogate outcome measures may speed up clinical research if they can
be measured earlier in a study than the primary outcome of interest. W
e review the justification for their use and conclude that reliance on
them may be harmful. Results obtained with surrogates should therefor
e be regarded as preliminary. Large, definitive trials with clinically
relevant outcomes should always be performed before new interventions
are accepted.